연한 갈색의 짧은 머리에 안경을 쓰고 회색 터틀넥과 짙은 블레이저, 진주 목걸이를 착용한 여성이 흐릿한 기업 법률 사무실 복도를 배경으로 미소를 짓고 있습니다.

코트니 C. 브린커호프

파트너

코트니 C. 브린커호프

파트너

Courtenay Brinckerhoff is an intellectual property lawyer, assisting international clients with all aspects of obtaining, defending, evaluating, licensing, and enforcing patents; and conducting freedom-to-operate and due diligence investigations. She is a partner and vice chair of the firm’s Intellectual Property Department, as well as the editor and primary author for Foley’s PharmaPatentsBlog.com, where she analyzes evolving patent office practices and precedential court decisions on emerging legal issues.

For more than 25 years, Courtenay has represented clients in diverse industries before the U.S. Patent Office, the Patent Trial and Appeal Board, and the U.S. Court of Appeals for the Federal Circuit. She has successfully represented clients in complex patent matters, including four-party interference, Inter partes Reexaminations, Inter partes Reviews, and ANDA litigation.

Courtenay works with clients across the chemical and biotechnology industries, including on innovations for pharmaceuticals and drug-device products, human and animal food products and nutraceuticals, and industrial technologies. Clients trust Courtenay to secure critical intellectual patent rights, including patents intended for listing in the Orange Book or eligible for listing in the Purple Book.

She has particular experience with transdermal pharmaceutical products (patches, gels, and liquids), oral dosage forms (including controlled/extended-release formulations), enzyme-based technologies, microbial technologies, diagnostic and therapeutic antibodies, active and passive immunization therapies, and personalized medicine, as well as with industrial films, carbon nanotube technologies, biofuels, and carbon capture technologies.

Courtenay has served as vice chair of the firm’s Chemical, Biotechnology & Pharmaceutical Practice and is an active member of the firm’s PTAB Trials Practice and Life Sciences Industry Team.

Prior to joining Foley as an associate, Courtenay clerked for the Honorable Alvin Anthony Schall on the U.S. Court of Appeals for the Federal Circuit. Prior to her clerkship, she worked at Foley as a patent agent and law clerk.

수상 및 표창

  • 뛰어난 변호사, 톰슨 로이터 (2025)
  • The Best Lawyers in America©, Patent Law (2021-2024) and Biotechnology and Life Sciences Practice (2023-2024)
  • IP Distinguished Alumni Award from George Mason University Antonin Scalia Law School (April 2017)
  • JD Supra Readers’ Choice Top Author (2017-2021) in the categories of pharmaceutical industry and patents for her work on the PharmaPatents blog
  • IAM Patent 1000 – The World’s Leading Patent Practitioners, patent prosecution (2014-2016, 2020-2021, 2024-2025)
  • Top Women in IP, Managing IP (2015)
  • IP Star, Managing IP (2015)

사고 리더십

Courtenay writes and speaks on topics important to clients in chemical, biotechnological, pharmaceutical, food, and personalized medicine industries. She has been an invited speaker at the AIPLA Annual Meeting, the FDLI Annual Meeting, the Intellectual Property Owner’s Association annual meeting, the PTAB Bar Association annual meeting, and the annual Advanced Patent Law Institute presented by the University of Texas School of Law, the United States Patent and Trademark Office, and George Mason University Antonin Scalia Law School.

Courtenay currently serves as a Vice Chair of the Intellectual Property Owner’s Association Patent Office Practice Committee and as a Vice Chair of the Appeals to the PTAB Committee of the PTAB Bar Association.

Courtenay has been following U.S. patent reform since its inception, and she and other Foley colleagues co-authored the treatise, America Invents Act: Law & Analysis (Wolters Kluwer 2012). The interface between patent law and FDA law is another area of interest, and she has written and spoken on issues including patent term extension, the scope of the Hatch-Waxman “safe harbor,” the ANDA litigation framework, and the biosimilars BPCIA framework.

 

2025년 10월 24일 제약 특허

(거의) 무료에 가까운 신속 검사를 위해 빠르게 행동하세요.

미국 특허청은 심사되지 않은 특허 출원의 적체를 효율적으로 줄이기 위해 고안된 새로운 파일럿 프로그램을 발표했습니다. The...
2025년 10월 21일 PTAB 시험 인사이트

미국 특허청장이 지적 재산권 및 PGR 기관의 결정을 통제합니다.

In what some are perceiving as the second blow of a one-two punch against patent trial proceedings conducted at the U.S. Patent and...
2025년 10월 16일 IP 소송 현황

USPTO, 지식재산권 절차의 임의 거부에 관한 규칙 제정안 발표

스콰이어스 국장이 발표한 첫 번째 규칙 제정 제안에서 USPTO는 다음과 관련된 실무 규칙을 수정할 것을 제안합니다.
2025년 10월 9일 제약 특허

미국 특허청에서 AI 생성 선행 기술 검색을 테스트하는 데 도움을 주시겠습니까?

One of the goals of the new Director of the United States Patent and Trademark Office (USPTO) is to improve patent examination efficiency...
2025년 9월 4일 제약 특허

연방 순회 재판, 기소 지연에 회의적

구글 대 소노스 사건에서 연방순회법원은 소송 중인 특허가 지연으로 인해 집행이 불가능하다는 주장을 합리적으로 처리했습니다....
2025년 6월 5일 영예 및 수상

IAM, 2025년판 'IAM 특허 1000: 세계 최고의 특허 실무자'에서 폴리 변호사와 관할 지역을 인정받다

폴리 앤 라드너 LLP의 17명의 변호사와 5개의 로펌이 2025년판 IAM 특허 1000: 세계 최고의 특허 전문가에 선정되었습니다.